After studies flag possible link between Novo's Ozempic and rare eye disorder, Danish agency calls for probe
It’s not a new question, but it is one that is gaining increased traction: Is there a link between Novo Nordisk’s diabetes and obesity superstar Ozempic and blindness? | After the recent release of two independent studies from the University of Southern Denmark suggested the use of Ozempic increases patients' chances of developing a rare eye disorder,
The maker of weight-loss and diabetes drugs has supercharged the Danish economy — but other businesses complain that’s left ...
Novo Nordisk made a submission to the U.S. Food and Drug Administration (FDA) nominating Novo Nordisk’s semaglutide ...
Construction has already begun on the Ozempic-producer’s new Danish production facility and 40,000m² warehouse.
Eli Lilly (LLY -1.28%) and Novo Nordisk (NVO 1.03%) have competed for decades. They're both leaders in the areas of insulin ...
The pharmaceutical company will establish a production facility in Odense to accommodate multiple product types within the ...
Ozempic maker Novo Nordisk A/S is investing 8.5 billion kroner ($1.2 billion) to build a new major factory in Denmark to help ...
Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks ...
Shortly after unveiling a $400 million upgrade at its campus in Hillerød, Denmark, Novo Nordisk is reinforcing its commitment ...
NVO's CagriSema target of up to 25% in long-term weight loss is highly promising vs. 15% through Wegovy and 20% through ...
Investors with a lot of money to spend have taken a bullish stance on Novo Nordisk NVO. And retail traders should know. We ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback